Michael Carr

Dr. Michael Carr

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
WSWeifeng Shi
Weifeng Shi
ZZZhong Zhang
Zhong Zhang
CLCheng Ling
Cheng Ling
WZWeimin Zheng
Weimin Zheng
CZChaodong Zhu
Chaodong Zhu
DHDesmond G. Higgins
Desmond G. Higgins

Verified
Journal Article
Open access
PDF file
Gabriel GonzalezGabriel Gonzalez
Gabriel Gonzalez
MCMichael Carr
Michael Carr
MKMasaaki Kobayashi
Masaaki Kobayashi
NHnozomu hanaoka
nozomu hanaoka
Tsuguto FujimotoTsuguto Fujimoto
Tsuguto Fujimoto
Enteroviruses (EVs) are responsible for extremely large-scale, periodic epidemics in pediatric cohorts, particularly in East and Southeast Asia. Clinical presentation includes a diverse disease spectrum, including hand-foot and mouth disease (HFMD), aseptic meningitis, encephalitis, acute flaccid paralysis, and acute flaccid myelitis. HFMD is predominantly attributable to EV-A types, including the major pathogen EV-A71, and coxsackieviruses, particularly CV-A6, CV-A16, and CV-A10. There have been multiple EV-A71 outbreaks associated with a profound burden of neurological disease and fatal outcomes in Asia since the early 1980s. Efficacious vaccines against EV-A71 have been developed in China but widespread pediatric vaccination programs have not been introduced in other countries. Encephalitis, as a consequence of complications arising from HFMD infection, leads to damage to the thalamus and medulla oblongata. Studies in Vietnam suggest that myoclonus is a significant indicator of central nervous system (CNS) complications in EV-A71-associated HFMD cases. Rapid response in HFMD cases in children is imperative to prevent the progression to a CNS infection; however, prophylactic and therapeutic agents have not been well established internationally, therefore surveillance and functional studies including development of antivirals and multivalent vaccines is critically important to reduce disease burden in pediatric populations.

1 January 2021 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
TMTobias Mourier
Tobias Mourier
MSMukhtar Sadykov
Mukhtar Sadykov
MCMichael Carr
Michael Carr
Gabriel GonzalezGabriel Gonzalez
Gabriel Gonzalez
WHWilliam W. Hall
William W. Hall
APArnab Pain
Arnab Pain
The extensive sequence data generated from SARS-CoV-2 during the 2020 pandemic has facilitated the study of viral genome evolution over a brief period of time. This has highlighted instances of directional mutation pressures exerted on the SARS-CoV-2 genome from host antiviral defense systems. In this brief review we describe three such human defense mechanisms, the apolipoprotein B mRNA editing catalytic polypeptide-like proteins (APOBEC), adenosine deaminase acting on RNA proteins (ADAR), and reactive oxygen species (ROS), and discuss their potential implications on SARS-CoV-2 evolution.

1 July 2006 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
P. Lewis WhiteP. Lewis White
P. Lewis White
RBRichard Barton
Richard Barton
MGMalcolm Guiver
Malcolm Guiver
CLChristopher J. Linton
Christopher J. Linton
SWSteve Wilson
Steve Wilson
RBRosemary A. Barnes
Rosemary A. Barnes

2 May 2013 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
CGCillian F. De Gascun
Cillian F. De Gascun
MCMichael Carr
Michael Carr
JC and BK polyomaviruses were discovered over 40 years ago and have become increasingly prevalent causes of morbidity and mortality in a variety of distinct, immunocompromised patient cohorts. The recent discoveries of eight new members of thePolyomaviridaefamily that are capable of infecting humans suggest that there are more to be discovered and raise the possibility that they may play a more significant role in human disease than previously understood. In spite of this, there remains a dearth of specific therapeutic options for human polyomavirus infections and an incomplete understanding of the relationship between the virus and the host immune system. This review summarises the human polyomaviruses with particular emphasis on pathogenesis in those directly implicated in disease aetiology and the therapeutic options available for treatment in the immunocompromised host.

1 August 2011 in Emerging Infectious Diseases
Verified
Journal Article
Open access
MCMichael Carr
Michael Carr
AKAdriana E. Kajon
Adriana E. Kajon
XLXiaoyan Lu
Xiaoyan Lu
LDLinda Dunford
Linda Dunford
POPaul O’reilly
Paul O’reilly
WHWilliam W. Hall
William W. Hall
Human adenovirus (HAdV) serotype 14 is rarely identified. However, an emerging variant, termed HAdV-14p1, recently has been described in the United States in association with outbreaks of acute respiratory disease with high rates of illness and death. We retrospectively analyzed specimens confirmed positive for HAdV by immunofluorescence, virus culture, or real-time PCR during July 1, 2009–July 31, 2010, and describe 9 cases of HAdV-14p1 infection with characteristic mutations in the fiber and E1A genes that are phylogenetically indistinguishable from the viruses previously detected in the United States. Three patients died; 2 were immunocompromised, and 1 was an immunocompetent adult. We propose that surveillance should be increased for HAdV-14p1 and recommend that this virus be considered in the differential diagnosis of sudden-onset acute respiratory disease, particularly fatal infections, for which an etiology is not clear.